載入...
COVID-19 and the nicotinic cholinergic system
The prevalence of smoking among hospitalised COVID-19 patients is low. COVID-19 manifestations could be linked to impairment of the cholinergic anti-inflammatory pathway. Nicotinic cholinergic agonists should be examined as potential therapeutic options. https://bit.ly/2zfUZ1S
Na minha lista:
| 發表在: | Eur Respir J |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
European Respiratory Society
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7248130/ https://ncbi.nlm.nih.gov/pubmed/32444400 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.01589-2020 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|